Actelis Networks Inc (OQ:ASNS)
Business Focus: Construction & Engineering
May 14, 2024 04:30 pm ET
Actelis Networks Reports Fiscal First Quarter 2024
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal first quarter ended March...
May 06, 2024 08:47 am ET
Actelis Receives Order and Delivers Instant, Secure Fiber-Grade Networking to Modernize City of Bakersfield, California
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has fulfilled a new order for the City of Bakersfield,...
May 02, 2024 08:37 am ET
Actelis Receives $2.3 Million Order for Immediate Delivery of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.’s Department of Transportation
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received an approximately $2.3 million order to supply...
Apr 04, 2024 08:30 am ET
Actelis Networks and Khushi Communications Partner to Enable Expansion of IoT Networks Throughout India
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has entered into a partnership agreement with Khushi...
Mar 26, 2024 04:30 pm ET
Actelis Networks Reports Fiscal Full Year 2023 Results
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, hybrid-fiber rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal full year 2023...
Mar 12, 2024 08:30 am ET
Actelis Networks and Netceed Sign Partnership Agreement to Extend Actelis’ Hybrid-Fiber Networking Solutions to Netceed’s North American Customer Base
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has signed a partnership agreement with Netceed, a leading...
Feb 29, 2024 08:30 am ET
Actelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber Security
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has achieved U.S. Department of Commerce National Institute of...
Feb 07, 2024 04:30 pm ET
Actelis Networks Announces New $1.5 Million Credit Line
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced the closing of a new credit line facility. The accounts receivable...
Feb 01, 2024 08:30 am ET
Actelis Receives Order For City of Napa Intelligent Traffic Management System
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that its hybrid-fiber connectivity solution has been recently deployed...
Jan 16, 2024 08:30 am ET
Actelis Announces U.S. Department of Defense JITC Labs Approval for Cybersecurity and Interoperability and Approved Products List Status
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that its cyber-hardened, hybrid-fiber networking solutions have been...
Dec 28, 2023 08:30 am ET
Actelis Receives Order From Major North American Rail Operator For Management Software And Services
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received an order for management software license and...
Dec 20, 2023 04:05 pm ET
Actelis Networks Announces Closing of $1.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced the closing of its previously announced private placement, priced...
Dec 18, 2023 08:37 am ET
Actelis Networks Announces $1.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has entered into definitive agreements for the purchase and...
Dec 14, 2023 08:30 am ET
Actelis Announces Order Received and Launch of New Last Mile Hybrid-Fiber Multi-Gigabit Broadband Solution For Buildings and IoT Applications
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced the official launch of the cyber and temperature hardened GigaLine 800...
Dec 06, 2023 08:45 am ET
Actelis Receives Order For Networking Of Traffic Management and Safety IoT Applications In The City of Everett, Washington
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received and has delivered a new order for multi-gigabit...
Nov 29, 2023 08:30 am ET
Actelis Receives Order From Major German Energy Provider For Encrypted, Cyber-Hardened, Hybrid-Fiber Networking
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received a new order to supply a major German provider...
Nov 20, 2023 08:30 am ET
Actelis Delivers Hybrid-Fiber Networking Solutions to US Naval Base In Asia-Pacific
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has delivered its cyber-hardened, hybrid-fiber networking...
Nov 14, 2023 04:30 pm ET
Actelis Networks Reports Third Quarter 2023
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment Hybrid-Fiber networking solutions for wide area IoT applications, today reported financial results for the fiscal third quarter...
Oct 24, 2023 08:30 am ET
Actelis Launches Unique, Ultra Low Power In-Building Gigabit Connectivity Solution For Instant Service Provisioning of Multi-Tenant Units
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced the official launch of the GigaLine 900, a first of its kind product...
Oct 17, 2023 08:30 am ET
Actelis Selected and Receives First Order to Provide IoT Networking To European Natural Gas System Operator
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received a first order to supply a major European natural...
Sep 28, 2023 09:31 am ET
Thinking about buying stock in Galecto Inc, Actelis Networks, ShiftPixy, Alpha Teknova, or SeaStar Medical Holding?
NEW YORK, Sept. 28, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GLTO, ASNS, PIXY, TKNO, and ICU.
Sep 27, 2023 04:30 pm ET
Actelis Achieves Third Party Validation For FIPS Cyber Protection Standard Required by Government Agencies
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has successfully achieved Third Party Validation for FIPS...
Aug 28, 2023 04:30 pm ET
Actelis to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, announced its participation in the H.C. Wainwright 25th Annual Global...
Aug 24, 2023 09:38 am ET
Actelis Networks Reports Second Quarter 2023
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal second quarter and first...
Aug 14, 2023 08:50 am ET
U.S. Air Force Selects Actelis for IoT Networking Modernization of a Major Air Force Base
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it was recently selected by the United States Air Force...
Aug 09, 2023 08:30 am ET
Actelis Receives Orders for Its Hybrid Copper Networking Solutions To Expedite IoT Modernization of Major Highway and Rail Systems Throughout Japan
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it has received several recent orders to deploy its...
Jul 12, 2023 04:05 pm ET
Actelis Networks Announces Appointment of Senior Vice President of Sales for the Americas
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced the appointment of Bret Harrison as the new Senior Vice...
Jun 27, 2023 08:00 am ET
Actelis Selected to Upgrade HVAC Networking Solution for United States Military Under Base Modernization Initiative
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that its hybrid fiber-copper networking solution has been...
Jun 16, 2023 08:30 am ET
Actelis Networks Launches Nine New High Performance 10Gbps Fiber Optic Product Series Adding to its GigaLine Product Family of Cyber-Hardened, Rapid Deployment Offering
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced the launch of a new line of advanced, software managed,...
May 22, 2023 08:00 am ET
Actelis To Present at the LD Micro Invitational XIII
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it will be attending the 13th Annual LD Micro...
May 12, 2023 08:30 am ET
Actelis Networks Reports Fiscal First Quarter 2023
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal first quarter ended March...
May 08, 2023 04:05 pm ET
Actelis Networks Announces Closing of $3.5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced the closing of its previously announced $3.5 million...
May 04, 2023 12:58 pm ET
Actelis Networks Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it has entered into definitive agreements for the...
May 03, 2023 04:15 pm ET
Actelis Networks Regains Compliance With Nasdaq Minimum Bid Price Requirement
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it received notice from The Nasdaq Stock Market (Nasdaq)...
May 01, 2023 08:00 am ET
Actelis Networks Showcases New Hybrid Fiber-Copper Solutions Extending Gigabit Speed Connectivity For IoT Applications and 18 Million Multiple Dwelling Units
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced the introduction of next generation hybrid fiber-copper...
Apr 19, 2023 04:15 pm ET
Actelis Networks Announces 1-For-10 Reverse Stock Split to Aid Compliance With Nasdaq Listing Requirements
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, announced that on April 18, 2023, the Company filed a Certificate of...
Apr 05, 2023 04:15 pm ET
City of West Sacramento Modernizes Traffic Management With Actelis’ Hybrid Fiber-Copper Solutions
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that the city of West Sacramento, CA, will be deploying...
Mar 29, 2023 04:05 pm ET
Actelis Networks Reports Fiscal Full Year 2022
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal full year 2022 ended...
Mar 22, 2023 04:30 pm ET
Actelis Networks to Report Fiscal Full Year 2022 Financial Results on Wednesday, March 29, 2023, at 4:30 p.m. ET
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, will hold a conference call on Wednesday, March 29, 2023, at 4:30 p.m....
Mar 08, 2023 08:00 am ET
Actelis Strengthens Global Footprint With Appointment Of New Asia-Pacific Regional Vice President
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced the appointment of Tzachy Givaty as Regional Vice President...
Feb 21, 2023 07:00 am ET
Actelis Selected by the City of Eugene for Traffic Modernization Project
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that the City of Eugene, Oregon has selected Actelis’ hybrid...
Jan 17, 2023 10:00 am ET
Sidoti's January Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / January 17, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 18-19, 2023. The links can also be found at www.sidoticonference.com/events.
Jan 13, 2023 04:15 pm ET
Actelis to Present at the Sidoti Virtual Conference on January 18th, 2023
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that Tuvia Barlev, Chief Executive Officer of the Company,...
Jan 03, 2023 04:05 pm ET
Actelis Selected By Northern Ireland Railways For Safety Critical Project
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it has been selected by Northern Ireland Railways (NI...
Dec 19, 2022 04:05 pm ET
Actelis Extends Cyber-Hardened, Fiber-Grade, Rapid Deployment Networking to On Base Facilities Using Existing Infrastructure
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported that an on base US Military implementation utilizing Actelis’...
Nov 22, 2022 07:00 am ET
Actelis Networks, Inc. Authorizes up to $1 Million Share Repurchase Program
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today announced that its Board of Directors has authorized a share repurchase...
Nov 11, 2022 04:05 pm ET
Actelis Networks Reports Third Quarter and First Nine Months of Fiscal 2022
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today reported financial results for the fiscal third quarter and first nine...
Nov 04, 2022 04:30 pm ET
Actelis Networks to Report Fiscal Third Quarter 2022 Financial Results on Friday, November 11, 2022, at 4:30 p.m. ET
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, will hold a conference call on Friday, November 11, 2022, at 4:30 p.m. Eastern...
Oct 24, 2022 04:30 pm ET
Actelis Selects Norseman Defense Technologies As Its Latest US Government Focused Sales Partner
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced it has selected Norseman Defense Technologies ("Norseman") as...
Oct 07, 2022 07:30 am ET
Actelis Releases to Customers its New, Powerful ML600DM IoT Networking Building Blocks
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, releases its new, powerful, ML600DM product line to customers. The...
Sep 12, 2022 07:30 am ET
The City of San Jose Chooses Actelis’ Solutions and Management Software to Advance Intelligent Transportation throughout Silicon Valley’s Tech Capital
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, was chosen by the city of San Jose to modernize and extend a state-of-the-art...
Sep 06, 2022 04:30 pm ET
Actelis to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, announced today that Tuvia Barlev, Chief Executive Officer, and Yoav Efron,...
Aug 29, 2022 04:30 pm ET
Actelis Ramps Up Rollout of IoT Networks for Major Airports Worldwide in Seven Countries Spanning America, Europe, and Asia
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, announced today that it has received $312,000 to-date in orders following...
Aug 11, 2022 04:05 pm ET
Actelis Networks Reports Second Quarter and First Half of Fiscal 2022
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today reported financial results for the fiscal second quarter and first six...
Aug 03, 2022 04:30 pm ET
Actelis Networks to Report Fiscal Second Quarter 2022 Financial Results on Thursday, August 11, 2022 at 4:30 p.m. ET
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, will hold a conference call on Thursday, August 11, 2022 at 4:30 p.m. Eastern...
Jun 22, 2022 04:25 pm ET
Actelis Networks Reports Fiscal First Quarter 2022 Results
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, reported financial results for the fiscal first quarter ended March 31, 2022....
Jun 15, 2022 04:30 pm ET
Actelis Networks to Report Fiscal First Quarter 2022 Financial Results on Wednesday, June 22, 2022 at 4:30 p.m. ET
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, will hold a conference call on Wednesday, June 22, 2022 at 4:30 p.m. Eastern...
May 17, 2022 04:30 pm ET
Actelis Networks, Inc. Announces Closing of Initial Public Offering and Partial Exercise of Over-Allotment Option by Underwriter
Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a provider of cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today announced the closing of its upsized underwritten initial public offering of...
May 13, 2022 07:30 am ET
Actelis Networks, Inc. Announces Pricing of its Initial Public Offering
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a provider of cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today announced the pricing of its initial public offering of 3,750,000 shares of its...
Feb 14, 2019 07:35 am ET
Consolidated Research: 2019 Summary Expectations for The Trade Desk, Aduro Biotech, Walker & Dunlop, California Resources, Century Casinos, and Arsanis — Fundamental Analysis, Key Performance Indicati
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Trade Desk Inc. (NASDAQ:TTD), Aduro Biotech, Inc. (NASDAQ:ADRO),...
Jan 05, 2019 05:43 pm ET
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition
NEW YORK, Jan. 5, 2019 /PRNewswire/ --
Dec 11, 2018 07:40 am ET
Report: Exploring Fundamental Drivers Behind GTT Communications, Midstates Petroleum, Arsanis, BioTelemetry, Dolby Laboratories, and Northern Dynasty Minerals — New Horizons, Emerging Trends, and Upco
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of GTT Communications, Inc. (NYSE:GTT), Midstates Petroleum Co. (NYSE:MPO),...
Nov 28, 2018 08:41 am ET
Thinking about buying stock in Aurora Cannabis Inc, Sphere 3D Corp, Arsanis, salesforce or Tilray Inc.?
NEW YORK, Nov. 28, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, ANY, ASNS, CRM, and TLRY.
Nov 27, 2018 07:00 am ET
Arsanis and X4 Pharmaceuticals Agree to Merger
Arsanis, Inc. (Nasdaq: ASNS) and privately-held X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics designed to improve immune cell trafficking to treat rare diseases...
Nov 09, 2018 08:00 am ET
Arsanis Reports Financial Results for Third Quarter 2018
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases, today reported financial results for the third quarter ended September...
Oct 17, 2018 07:20 am ET
Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Arsanis, Inc. (NASDAQ:ASNS), Dynavax Technologies Corporation...
Oct 03, 2018 09:14 am ET
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018
WASHINGTON, Oct. 3, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations, announced today that 16 of its member companies will present data from their clinical and research programs at IDWeek 2018 to be held October 3-7 in San Francisco. AWG members are presenting a total of 40 poster presentations, four oral abstract presentations and four features within the symposium entitled "Exploring the Antibiotic Pipeline 2018."
Aug 20, 2018 07:55 am ET
New Research: Key Drivers of Growth for Harmonic, Astec Industries, Marlin Business Services, Arsanis, SunOpta, and Rhythm Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Produ
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc. (NASDAQ:HLIT), Astec Industries, Inc. (NASDAQ:ASTE), Marlin...
Aug 13, 2018 08:00 am ET
Arsanis Reports Financial Results for Second Quarter 2018
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases, today reported financial results for the second quarter ended June 30,...
Jun 28, 2018 01:05 pm ET
INVESTOR ALERT: Investigation of Arsanis Announced by Holzer & Holzer
Holzer & Holzer, LLC is investigating whether Arsanis, Inc. (“Arsanis”
or the “Company”) (NASDAQ: ASNS) complied with the federal securities
laws. On June 28, 2018, Arsanis announced the discontinuation of its
Phase 2 clinical trial of ASN100, a preventive drug for mechanically
ventilated patients with a high risk of contracting pneumonia. Arsanis
disclosed that an analysis completed by an independent drug review
committee found that continuing the trial was “futile” because the
target primary end-point likely would not be met upon completion. T
Jun 28, 2018 07:00 am ET
Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100
Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced the discontinuation of its Phase 2 clinical trial of ASN100 for...
Jun 14, 2018 08:00 am ET
Arsanis Out-Licenses Preclinical Stage Klebsiella pneumoniae Monoclonal Antibodies from ASN300 Program
Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced that it has entered into an agreement under which BB200, LLC, a...
Jun 05, 2018 07:50 am ET
Investor Expectations to Drive Momentum within Oxford Immunotec Global, Financial Engines, Brookfield Property Partners, Arsanis, QIWI, and Stitch Fix — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oxford Immunotec Global PLC (NASDAQ:OXFD), Financial Engines, Inc....
May 10, 2018 07:00 am ET
Arsanis Reports Business Highlights and Financial Results for First Quarter 2018
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody (mAb) immunotherapies to address
serious infectious diseases, today reported business highlights and
financial results for the first quarter ended March 31, 2018.
Apr 20, 2018 10:17 am ET
Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
WASHINGTON, April 20, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG) today announced that thirteen of its member companies will present data from their clinical and research programs at the annual meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) to be held April 21 - 24 in Madrid, Spain.
Apr 17, 2018 08:00 am ET
Arsanis to Present at the 28th European Congress of Clinical Microbiology and Infectious Diseases
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody (mAb) immunotherapies to address
serious infectious diseases, announced today that the company will
present five scientific posters at the 28th European Congress of
Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain
from April 21 – 24, 2018. The posters will highlight new research
findings and supportive data across all mAb programs in Arsanis’
pipeline.
Apr 09, 2018 07:40 am ET
Research Report Identifies Teck Resources, Adverum Biotechnologies, BeiGene, IPG Photonics, Arsanis, and G1 THERAPEUTICS with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Teck Resources Ltd (NYSE:TECK), Adverum Biotechnologies,...
Apr 04, 2018 08:00 am ET
Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, today announced that it has entered into an
agreement under which BB100, LLC has secured an exclusive, worldwide
preclinical development license, and an option to a clinical development
and commercialization license, to monoclonal antibodies (mAbs) targeting E.
coli that were discovered by Arsanis in its ASN200 program.
Mar 20, 2018 08:00 am ET
Arsanis to Present at the Needham & Company 17th Annual Healthcare Conference
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, announced today that CEO René Russo,
PharmD, BCPS, will present a company overview at the Needham & Company
17th Annual Healthcare Conference on March 27, 2018, at 12:45 p.m. ET.
Mar 15, 2018 08:10 am ET
Report: Exploring Fundamental Drivers Behind Mountain Province Diamonds, Limoneira, Arsanis, ExlService, Argo Group International, and Cellectis S.A. — New Horizons, Emerging Trends, and Upcoming Deve
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mountain Province Diamonds Inc. (NASDAQ:MPVD), Limoneira...
Mar 14, 2018 08:00 am ET
Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies
Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, today announced that the United States
Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9914767 to
the company. This patent broadly claims composition of matter for
antibodies that cross-neutralize Staphylococcus aureus alpha
hemolysin (Hla) and up to four additional S. aureus leukocidins
targeted by ASN-1, one of the two antibodies in the company’s lead
Mar 09, 2018 07:00 am ET
Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017
Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, today reported financial results and
business highlights for the fourth quarter and full year ended December
31, 2017.
Mar 05, 2018 08:00 am ET
Arsanis to Present at the 38th Annual Cowen and Company Health Care Conference
Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, announced today that CEO René Russo,
PharmD, BCPS, will present a company overview at the 38th
Annual Cowen and Company Health Care Conference on March 12, 2018, at
12:00 p.m. ET.
Nov 20, 2017 04:10 pm ET
Arsanis Announces Closing of Initial Public Offering
Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company
focused on applying monoclonal antibody immunotherapies to address
serious infectious diseases, today announced the closing of its initial
public offering of 4,600,000 shares of its common stock at a public
offering price of $10.00 per share, including 600,000 additional shares
of common stock issued upon the exercise in full by the underwriters of
their over-allotment option. The gross proceeds to Arsanis from the
offering were $46.0 million, before deducting underwriting d
Nov 15, 2017 11:20 pm ET
Arsanis Announces Pricing of Initial Public Offering
WALTHAM, Mass. and VIENNA, Austria, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Arsanis, Inc., a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced the pricing of its initial public offering of...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.